Unlocking Protein Insights with NMR Spectroscopy

Nuclear Magnetic Resonance (NMR) spectroscopy is one of the most powerful techniques available for studying biomolecules in solution. Unlike many analytical methods, NMR can provide detailed information on protein structure, stability, dynamics, and molecular interactions under near-physiological conditions.

At Sygnature Discovery, we have extensive experience producing isotope-labeled proteins to support NMR studies. Combined with specialist NMR expertise and access to leading NMR facilities, we can support a range of applications from protein quality assessment through to protein-ligand interaction analysis and structural characterization.

NMR exploits the magnetic properties of certain atomic nuclei, including hydrogen (¹H), nitrogen (¹⁵N), and carbon (¹³C). When placed in a strong magnetic field and exposed to radiofrequency pulses, these nuclei generate signals that provide detailed information about their molecular environment.

Since its development in the mid-20th century, advances in superconducting magnet technology and data processing have transformed NMR into a versatile tool for investigating proteins, nucleic acids, carbohydrates, and small molecules.

For many protein-focused applications, isotopically labeled proteins containing ¹⁵N and ¹³C are produced to improve sensitivity and enable residue-specific analysis. These labeled proteins are typically generated through recombinant expression in bacterial systems using isotope-enriched growth media.

One of the most valuable applications of NMR is the rapid assessment of protein quality.

For unlabeled proteins, one-dimensional (1D) proton NMR spectra can provide information about whether a protein is folded or unfolded. Well-folded proteins produce highly dispersed resonances, whereas unfolded proteins exhibit a much narrower range of signals.

When ¹⁵N-labeled proteins are available, two-dimensional (2D) NMR experiments provide significantly greater detail. These spectra can act as molecular fingerprints, allowing scientists to assess protein integrity, stability, and conformational changes with residue-level resolution.

This capability makes NMR a valuable quality-control tool during protein production and characterization workflows.

Figure comparing folded and unfolded protein states using NMR spectroscopy. Panel A shows overlaid one-dimensional proton NMR spectra, with folded protein peaks in black and unfolded protein peaks in red. Panel B shows overlaid two-dimensional HSQC spectra, illustrating distinct signal distributions and spectral dispersion between folded and unfolded protein conformations.
Figure 1. 1D and 2D-NMR spectra of folded (black) and unfolded proteins (red). A) According to the nature of the protons, they experience a specific frequency in the H dimension; see highlighted regions on top of the figure. B) Increasing the dimensionality of the amide region (H/N correlation spectrum).

NMR is uniquely suited to studying molecular interactions in solution and has become an important technique in drug discovery, particularly for fragment screening and hit validation.

One of its key strengths is the ability to detect interactions across a wide range of affinities while providing atomic-level information about binding events.

Two complementary approaches are commonly used.

In ligand-observed experiments, the small molecule acts as the reporter molecule.

These methods do not require isotope-labeled protein and can be applied to proteins of virtually any size.

Common techniques include:

  • Saturation Transfer Difference (STD) NMR
  • WaterLOGSY
  • ¹⁹F-based NMR assays

These approaches are widely used to identify and confirm binding interactions during early-stage drug discovery and fragment screening campaigns (Figure 2).

Illustration of ligand-binding detection methods used in fragment-based drug discovery. The left panel shows a protein surface with ligand-binding regions monitored using STD, Water-LOGSY and ¹⁹F-FAXS NMR techniques. The right panel compares NMR signal responses in the presence and absence of a binding compound, demonstrating how each method identifies ligand interactions with the target protein.
Figure 2. Methodologies to explore binding process between small molecules and proteins. On the left panel is the 3D representation of the molecules involve in the interaction. On the right panel is the graphical representation of the expected resonances for no binders and binders, for each methodology.

Protein-observed experiments use ¹⁵N- or ¹³C-labeled proteins and provide more detailed information about the interaction (Figure 3).

By monitoring changes in individual resonances during ligand titration experiments, it is possible to:

  • Identify binding regions on the protein
  • Monitor transient and stable interactions
  • Estimate binding affinity
  • Support structural modeling of protein-ligand complexes

Importantly, NMR can evaluate interactions with a wide range of binding partners, including small molecules, peptides, proteins, nucleic acids, carbohydrates, and lipids.

Scientific figure showing NMR-based analysis of protein interactions with peptidoglycan. Panel A displays overlaid two-dimensional ¹H-¹⁵N NMR spectra of PBP4 S75C, highlighting chemical shift changes following treatment with peptidoglycan and muramidase. Arrows indicate protein residues affected by binding. Panel B shows two views of the protein surface structure rotated by 180 degrees, with red regions identifying interaction sites mapped from the NMR data.
Figure 3. Extracting structural information of protein ligand interactions from NMR. A) Example of ligand titrations followed by H/N-2D NMR spectra. Trend of the residues involved in the interaction are shown by black arrows. B) 3D reconstruction model based on CSP restraints obtained from A). From Maya-Martinez et al. Front. Microbiol. 18(9) (2019)

NMR provides a unique combination of structural, biophysical, and interaction data that can support multiple stages of a discovery program.

Applications include:

  • Protein quality control
  • Stability assessment
  • Fragment screening
  • Hit validation
  • Binding-site characterization
  • Dynamic conformational analysis
  • Structural biology studies

By revealing how proteins behave and interact in solution, NMR can help researchers gain confidence in candidate molecules and make better-informed decisions during drug discovery.

NMR remains one of the most versatile techniques available for characterizing proteins and molecular interactions. Whether assessing protein quality, validating ligand binding, or investigating molecular mechanisms, NMR provides insights that are often difficult to obtain through other analytical approaches.

Combined with expertise in recombinant protein production and isotope labeling, NMR can play a valuable role in addressing challenging protein science and drug discovery questions.

  1. C. Raingeval, et al., 1D NMR WaterLOGSY as an efficient method for fragment-based lead discovery. J. Enzyme Inhib. Med. Chem. 34, 1218–1225 (2019).
  2. R. S. Norton, E. W. W. Leung, I. R. Chandrashekaran, C. A. MacRaild, Applications of 19F-NMR in fragment-based drug discovery. Molecules 21 (2016).
  3. M. P. Williamson, Using chemical shift perturbation to characterise ligand binding. Prog. Nucl. Magn. Reson. Spectrosc. 73, 1–16 (2013).
  4. Maya-Martinez, et al., Recognition of Peptidoglycan Fragments by the Transpeptidase PBP4 From Staphylococcus aureus. Front. Microbiol. 18(9) (2019)